LIVE
Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constructive on the hospital chain's long-term prospects, though some caution that valuations are rich. Here's what experts recommend for allotted investors and those considering fresh entry.
Manipal Health shares list at 11% premium to beat GMP estimates. What should allotted investors do?
Impact Score
Market Sentiment
→NeutralPrimary Sectors
Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constructive on the hospital chain's long-term prospects, though some caution that valuations are rich. Here's what experts recommend for allotted investors and those considering fresh entry.
Key Highlights
Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations.
Brokerages remain constructive on the hospital chain's long-term prospects, though some caution that valuations are rich.
Here's what experts recommend for allotted investors and those considering fresh entry..
Source
Economic Times
Published
3h ago
Impact Score
70 / 100
Category
Indian Markets
Moderate near-term volatility expected while markets assess implications for Indian Markets.
What this means
No linked events found.